Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | IL23A |
| Upstream (Parents) |
|---|
| (<<) ASNS → IL23A |
| (<<) CBS → IL23A |
| (<<) DAZAP2 → IL23A |
| (<<) E2F3 → IL23A |
| (<<) GDF15 → IL23A |
| (<<) HMGA2 → IL23A |
| (<<) KLF7 → IL23A |
| (<<) MAPK9 → IL23A |
| (<<) MYC → IL23A |
| (<<) OSBPL8 → IL23A |
| (<<) PDK2 → IL23A |
| (<<) PKM2 → IL23A |
| (<<) SOX9 → IL23A |
| (<<) SP3 → IL23A |
| (<<) TTC9 → IL23A |
| (<<) TUBA1A → IL23A |
| Downstream (Children) |
|---|
| IL23A → ACTC1 (>>) |
| IL23A → ASB1 (>>) |
| IL23A → DUSP9 (>>) |
| IL23A → GNA11 (>>) |
| IL23A → HDAC4 (>>) |
| IL23A → MYL6B (>>) |
| IL23A → PHLDA1 (>>) |
| IL23A → RRP15 (>>) |
| IL23A → SOX2 (>>) |
| IL23A → SYNGR4 (>>) |
| IL23A → TYRO3 (>>) |
